PaxMedica

IPO: US:PXMD

Company Description

Phase 2 biotech developing therapies for neurodevelopmental disorders.

Filing Information

File Date

7/2/2020

File Shares

2,500,000.00

Low Price Range

$5.50

High Price Range

$6.50

Proposed Offering Amount

$15,000,000

Exchange

Nasdaq

Underwriter Information

Bookrunner

The Benchmark Company

Bookrunner

Brookline Capital Markets

Bookrunner

N/A

At a Glance

Company

PaxMedica

Address

City/State

Woodcliff Lake, NJ

Phone

N/A

Web

www.paxmedica.com

Industry

Health-Biotech

Employees

4

Founded

2018

Financial Information

Ltm Date

N/A

Ltm Sales

N/A

Employees

N/A

Use of Proceeds

Clinical trials

IPO Discussion

MarketWatch News on PXMD

No news currently available
Link to MarketWatch's Slice.